Screening of Low Responders for Aneuploidy to Improve Reproductive Efficiency
Completed · Not applicable
Conditions studied: Infertility
In brief
The purpose of this study is to assess the impact of Comprehensive Chromosome Screening(CCS) on patients with low ovarian reserve in an effort to improve success during in vitro fertilization and decrease the time to successful pregnancy.
Key facts
- Study ID
- NCT01977144
- Run by
- Reproductive Medicine Associates of New Jersey
- People needed
- 206
- Starts
- 2013-09-25
- Expected to finish
- 2020-01-01
- Last updated by the study team
- 2022-01-14
Who can join
Age: 18 and older, up to 43. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Age of female partner < 43 y/o AMH < 1.1 OR BAFC < 8 (within previous year) Male must have >100,000 motile sperm BMI < 32
You may not qualify if…
- Diagnosis of endometrial insufficiency Use of oocyte donor/gestational carriers Use of surgical sperm or DNA Banking Communicating hydosalpinges (HSG) Single gene disorders or sex selection Participation in another study
Where it is running
- Reproductive Medicine Associates of New Jersey — Basking Ridge, New Jersey, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.